AzTrials
AzTrials

Corneal AstigmatismNCT07081919

Effectiveness, Stability and Influence Factors of Femtosecond Laser Assisted Cataract Surgery

An observational study of Corneal Astigmatism and Cataract, run by Eye & ENT Hospital of Fudan University at 1 site in China.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

What is this study about? This study looks at whether a laser procedure called femtosecond laser-assisted arcuate keratotomy (FSAK) helps people with both cataracts and mild astigmatism see more clearly after cataract surgery. Astigmatism causes blurry vision because the front of the eye (cornea) is curved unevenly. Read more about this study

Who is it for?
Ages 20 to 80 years
Conditions the study is for
Corneal Astigmatism, Cataract
What is being tested?
femtosecond laser-assisted arcuate keratotomy (FSAK) combined with standard cataract surgery
Type of treatment
Surgery or procedure
How many people
105 participants
Where
1 siteChina
Study dates
22 Apr 2025to 22 Apr 2031
How long will I take part?
5 Years
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients with regular corneal astigmatism of 0.75-2.0 D who plan to undergo cataract surgery. Aged between 20 and 80 years old.

Who may be able to join

  • Age: 20-80 years
  • Age-related cataracts
  • Regular corneal astigmatism (0.75-2.0 diopters) confirmed by Pentacam/IOLMaster 700
  • Surgical Plan: Scheduled for femtosecond laser-assisted cataract surgery
  • Central corneal thickness ≥500 µm
  • Endothelial cell count ≥2,000 cells/mm²
  • Best-corrected visual acuity (BCVA) improvable to ≥20/40

Who cannot join

  • Prior corneal refractive surgery (e.g., LASIK, PRK)
  • Intraocular surgery (e.g., glaucoma filtering surgery)
  • Irregular astigmatism (keratoconus, scarring, post-traumatic distortion)
  • Active ocular inflammation or infection
  • Corneal endothelial disease (e.g., Fuchs' dystrophy)
  • Severe dry eye (Schirmer test ≤5 mm/5 min)
Show all 13Show fewer
  • Uncontrolled glaucoma (IOP >21 mmHg on medication)
  • Macular pathology (e.g., AMD, DME affecting visual potential)
  • Amblyopia
  • Autoimmune diseases affecting cornea (e.g., rheumatoid arthritis, Sjögren syndrome)
  • Diabetes mellitus with retinopathy
  • Pregnancy/Lactation
  • Inability to complete 5-year follow-up

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Jin Yang, PhD contact

13671632525

jin_er76@hotmail.com

China1 site, 1 recruiting
  • Eye and Ear, Nose, and Throat Hospital of Fudan University

    Shanghai, Shanghai Municipality, 200031

    Jin Yang, PhD, 13671632525, jin_er76@hotmail.com

    Recruiting

Other trials in China

About this study

What is this study about? This study looks at whether a laser procedure called femtosecond laser-assisted arcuate keratotomy (FSAK) helps people with both cataracts and mild astigmatism see more clearly after cataract surgery. Astigmatism causes blurry vision because the front of the eye (cornea) is curved unevenly. The FSAK procedure uses a computer-guided laser to make tiny, precise cuts in the cornea during cataract surgery to fix this curve. the investigators want to see if this improves vision long-term (up to 5 years) and what factors affect how the investigatorsll it works.

Who can join? the investigators are looking for adults aged 20-80 years who:

Read more

Have cataracts and mild-to-moderate astigmatism (0.75-2.0 diopters) Plan to have cataract surgery Have not had prior eye surgeries (like LASIK) Do not have severe dry eye or other eye diseases (like glaucoma or retina problems) What will happen in the study?

Surgery: Participants will have cataract surgery combined with the FSAK procedure. The surgeon uses a laser to make tiny curved cuts in the cornea to reshape it.

Follow-up visits: Participants will have regular eye check-ups for 5 years after surgery. These include:

Vision tests (reading eye charts) Measurements of the eye's shape using painless imaging machines Questionnaires about vision quality and daily activities Time commitment: Visits happen at 1 the investigatorsek, 1 month, 3 months, 6 months, 1 year, 2 years, and 5 years after surgery. Each visit takes about 1-2 hours.

Why is this study important? FSAK may help people with astigmatism see clearly after cataract surgery without needing glasses as often. By tracking results for 5 years, the investigators'll learn how long the benefits last and who benefits most. This could help doctors better personalize treatment in the future.

Who is running the study? Eye doctors at Fudan University Eye \& ENT Hospital (Shanghai) and Shanghai Peace Eye Hospital. About 105 people will take part.

Read the detailed description

Study Description for General Audience

What's the problem? Many people with cataracts also have an irregularly curved front surface of the eye (called astigmatism). After cataract surgery, this astigmatism can still cause blurry or distorted vision, making everyday tasks like reading or driving difficult. While glasses or special lenses can help, many hope to reduce their dependence on them after surgery.

What's being tested?

This study evaluates a laser procedure called Femtosecond Laser-Assisted Arcuate Keratotomy (FSAK). During cataract surgery:

A computer-guided laser makes tiny, curved incisions in the cornea (the eye's clear front window).

These precise incisions gently reshape the cornea to improve its natural curve. Think of it like a sculptor smoothing uneven surfaces-but using light-speed technology.

Why is this study unique?

While FSAK isn't brand new, the investigators lack long-term data on:

How the investigatorsll it holds up over 5+ years. Which factors predict success (e.g., does participantsr eye's shape or pressure affect results?).

the investigators're following participants for 5 years to ansthe investigatorsr these questions-far longer than most existing studies.

What will participants experience?

Surgery: FSAK is combined with standard cataract removal. The laser step adds only minutes.

Follow-ups: Painless check-ups at 1 the investigatorsek, 1 month, 3 months, 6 months, 1 year, 2 years, and 5 years after surgery. These involve:

Reading eye charts. Quick scans to map the eye's surface. Short questionnaires about vision quality (e.g., glare at night or reading small print).

Why does this matter?

If successful, FSAK could:

  • Help people see clearly longer after cataract surgery.
  • Reduce the need for glasses or contacts.
  • Give doctors better tools to personalize treatment.

Who's involved?

Led by eye specialists at Fudan University Eye \& ENT Hospital and Shanghai Peace Eye Hospital.

Being tested
femtosecond laser-assisted arcuate keratotomy (FSAK) combined with standard cataract surgery
Keywords
femtosecond laser-assisted arcuate keratotomy, cataract surgery, corneal astigmtism, astigmatism treatment stability, predictors of surgical outcomes
Medical subject headings
Astigmatism, Cataract

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • femtosecond laser-assisted arcuate keratotomy (FSAK) combined with standard cataract surgeryProcedure or surgery

    1. 5-year follow-up assessing stability of astigmatism correction. Most FSAK studies track ≤2 years. This addresses critical evidence gaps in durability
    2. Combines topographic data with patient-reported visual function (VF-14/QoV questionnaires at all visits. Links anatomical changes to real-world visual experiences
Study groups in NCT07081919
Study groupRoleWhat they receive
FSAK with Cataract SurgeryParticipants in this group undergo femtosecond laser-assisted arcuate keratotomy (FSAK) combined with standard cataract surgery
Receives: Procedure: femtosecond laser-assisted arcuate keratotomy (FSAK) combined with standard cataract surgery

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in corneal astigmatism magnitude (diopters) from baseline

    Measured: Preoperative; 1 week postoperatively, 1 month postoperatively, 3 months postoperatively, 6 months postoperatively, 1 year postoperatively, 2 years postoperatively, 5 years postoperatively

Secondary outcomes (6)
  1. Visual Acuity-UCVA

    Uncorrected Distance Visual Acuity (UDVA) at 5m (logMAR)

    Measured: Preoperative; 1 week postoperatively, 1 month postoperatively, 3 months postoperatively, 6 months postoperatively, 1 year postoperatively, 2 years postoperatively, 5 years postoperatively

  2. Visual acuity-BCVA

    Best-Corrected Visual Acuity (BCVA) at 5m (logMAR)

    Measured: Preoperative; 1 week postoperatively, 1 month postoperatively, 3 months postoperatively, 6 months postoperatively, 1 year postoperatively, 2 years postoperatively, 5 years postoperatively

  3. Manifest refraction spherical equivalent (MRSE) in Diopter (D)

    Measured: Preoperative; 1 week postoperatively, 1 month postoperatively, 3 months postoperatively, 6 months postoperatively, 1 year postoperatively, 2 years postoperatively, 5 years postoperatively

  4. Corneal Topography

    Corneal Topography assesses corneal curvature, with data collected using the Pentacam instrument and IOL Master. The measured outcome reflects the corneal's refractive power and shape characteristics. Corneal curvature is reported in diopters (D) , a standard unit for quantifying refractive power in ophthalmic measurements.

    Measured: Preoperative; 1 week postoperatively, 1 month postoperatively, 3 months postoperatively, 6 months postoperatively, 1 year postoperatively, 2 years postoperatively, 5 years postoperatively

  5. Objective Optical Quality

    Objective visual quality is evaluated by measuring Total ocular higher - order aberrations (HOAs, unit: µm) and Strehl ratio (SR) using the iTrace instrument. Total ocular higher - order aberrations reflect the deviation of the eye's optical system from an ideal state, where higher values generally indicate greater optical imperfections that may disrupt visual clarity. The Strehl ratio, on the other hand, quantifies the quality of optical imaging; a higher SR (ranging from 0 to 1, with 1 representing ideal optical quality) signifies better visual quality, as it relates to the concentration of light in the retinal image. These metrics, derived from iTrace measurements, provide objective assessments of how well the eye processes visual input, crucial for evaluating surgical outcomes (e.g., cataract or refractive surgery) and ocular health.

    Measured: Preoperative; 1 week postoperatively, 1 month postoperatively, 3 months postoperatively, 6 months postoperatively, 1 year postoperatively, 2 years postoperatively, 5 years postoperatively

  6. Patient-Reported Outcomes

    bjective visual quality can be assessed with the Visual Function-14 (VF-14) questionnaire, which evaluates 14 vision-dependent daily activities. Patients self-rate their functional limitations, with scores ranging from 0 (worst) to 100 (best), where higher scores indicate better visual function. It is administered preoperatively and 3 months postoperatively to measure changes, with a minimal clinically important difference of 15.57, meaning a score change exceeding this value signifies a meaningful improvement The DOI of reference for visual function questionnaire is 10.1016/j.ophtha.2010.04.009.

    Measured: Preoperative; 1 week postoperatively, 1 month postoperatively, 3 months postoperatively, 6 months postoperatively, 1 year postoperatively, 2 years postoperatively, 5 years postoperatively

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Jul 2025
  2. Study start22 Apr 2025
  3. Primary completion22 Apr 2030 (estimated)
  4. Study completion22 Apr 2031 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
105 participants (estimated)
Target duration
5 Years
IDs, dates and publications
ClinicalTrials.gov ID
NCT07081919
Sponsor's protocol ID
FSAK during cataract surgery
Status last verified
Jul 2025
First submitted
1 Jun 2025
Last updated
23 Jul 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Data contain sensitive biometric identifiers (e.g., corneal topography maps) that cannot be fully de-identified

Questions about this trial

What is this clinical trial studying?

An observational study of Corneal Astigmatism and Cataract, run by Eye & ENT Hospital of Fudan University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 23 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Jin Yang, PhD (13671632525, jin_er76@hotmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in corneal astigmatism magnitude (diopters) from baseline (time frame: Preoperative; 1 week postoperatively, 1 month postoperatively, 3 months postoperatively, 6 months postoperatively, 1 year postoperatively, 2 years postoperatively, 5 years postoperatively). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Jul 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in